• By Goodwill
  • 11 Comments
  • September 4, 2023

IPO : Jupiter Life Line Hospitals Limited

 SYMBOL JLHL
 ISSUE TYPE Book Built Issue IPO
 ISSUE OPENS ON September 06, 2023 (Wednesday)
 ISSUE CLOSES ON September 08, 2023 (Friday)
 ISSUE PRICE Rs.695 To Rs.735 per share
 ISSUE SIZE Up to Rs.869.08 Crores
 FACE VALUE Rs.10 per share

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.

Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the “Jupiter” brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.

According to the CRISIL Report, the company’s Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).

 MINIMUM BID 20 shares
 MINIMUM AMOUNT  Rs.14,700
 MAXIMUM BID 260 shares
 MAXIMUM AMOUNT  Rs.1,91,100
 LISTING DATE September 18,2023 (Monday)
 LISTING AT NSE-BSE

The company’s inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.

Objects of the Issue

The company intends to utilize the net proceeds from the issue towards the funding of the following objects:

  1. Repayment/pre-payment, in full or part, of borrowings availed from banks by the company and Material Subsidiary; and
  2. General corporate purposes.
    • SMART IPO using UPI, you can now apply online
      For Existing Clients : https://gudwil.in/IPO
      Open an account :  https://gudwil.in/smart
      Further any clarification, feel free to contact your Branch / Relationship Manager.For all your investment needs feel free to reach us. Give us a missed call at 90037 90027. For Support: 044-40329999

      Warm Regards,
      Team Goodwill

      DISCLAIMER : Investments in the securities market are subject to market risk. Read all the related documents carefully before investing. The data and information herein provided are believed to be reliable, but Goodwill Wealth Management Pvt. Ltd., does not warrant its accuracy or completeness. Goodwill Wealth Management Pvt. Ltd., or any of its employees are not liable for any action taken by any party based on the above information. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Special note: Short-term trading on the basis of technical is high risk and skill-oriented venture and may result in huge losses also. Traders doing so are doing at their own risk. We are not responsible for any damages. Note: The material is being provided to you for educational purposes only and does not constitute investment advice; returns mentioned herein are in no way a guarantee or promise of future returns. See Disclaimer, Privacy Policy @ https://gwcindia.in/Disclaimer

Comments

  1. Ivygef
    December 17, 2023

    [url=http://finasteride.best/]finasteride 5 mg daily[/url]

  2. ElwoodMip
    December 17, 2023

    [url=https://amoxicillin.boutique/]amoxicillin 200 mg tablet[/url]

  3. ElwoodMip
    January 1, 2024

    [url=https://tadalafil.cyou/]cialis 20mg pills[/url]

  4. Ivygef
    January 2, 2024

    [url=http://accutane.guru/]isotretinoin accutane[/url]

  5. Ivygef
    January 17, 2024

    [url=https://tadalafil.cfd/]5mg cialis from canada[/url]

  6. ElwoodMip
    January 17, 2024

    [url=https://doxycycline.cfd/]where can i get doxycycline over the counter[/url]

  7. semaglutide canada pharmacy
    February 1, 2024

    [url=https://rybelsus.us.com/]ozempic tab 7mg[/url]

  8. brand ozempic
    February 3, 2024

    [url=https://semaglutide.party/]ozempic semaglutide tablets 3mg[/url]

  9. wegovy 21 mg
    February 15, 2024

    [url=http://semaglutidetabs.com/]semaglutide online order[/url]

  10. wegovy buy online
    February 19, 2024

    [url=http://semaglutide.company/]semaglutide australia online[/url]

  11. ozempic injections
    February 29, 2024

    [url=http://ozempic.pics/]ozempic tab 3mg[/url]

Leave a Reply

Your email address will not be published. Required fields are marked *